HALOPERIDOL DECANOATE Recall D-0368-2025
Description: Haloperidol Decanoate Injection, 100 mg/mL*, 1 x 1 mL Single-Dose Vial, Rx only, Manufactured by: Somerset Therapeutics Limited, #54/1, Boodhihal Village, Nelamangala, Bangalore - 562123, Karnataka, India, Manufactured for BluePoint Laboratories, NDC 68001-581-41.
HALOPERIDOL DECANOATE Recall D-0368-2025 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-0368-2025 |
| Event ID | 96636 |
| Brand | HALOPERIDOL DECANOATE |
| Generic Name | HALOPERIDOL DECANOATE |
| Manufacturer | HALOPERIDOL DECANOATE |
| Original Package? | 1 |
| Active Substance | HALOPERIDOL DECANOATE |
| Drug Route | INTRAMUSCULAR |
| Distribution | Nationwide in the USA |
| Quantity | 14,189 vials |
| Recall Reason | Lack of assurance of sterility. Bacterial contamination detected in some media fill units |
| Drug Classification | Class II |
| Drug Code Info | 20250430 |
| Product NDC | 68001-578 68001-579 68001-580 |
| Drug UPC | 0368001578592 0368001581417 0368001579599 |
| Recall Initiation Date | 20250402 |
| Report Date | 20250430 |
| Classification Date | 20250418 |
| Address | 2550 John Glenn Ave Ste AN/A Columbus, OH 43217-1188 United States |
| Recalling Firm | Amerisource Health Services LLC |
| Initial Notification | Letter |
| Unique Ingredient Identifier | AC20PJ4101 |
| Drug Application Number | ANDA209101 |
| Structured Product Labeling (SPL ID) | 048557ea-f859-f0f2-e063-6294a90af5ab |
| Structured Product Labeling (SPL Set ID) | f2d14406-2ad4-4c5b-9c24-a026f27b415d |
| Similar To |